James G Beeson Selected Research

RTS malaria vaccine

1/2021	RTS,S/AS01E malaria vaccine induces IgA responses against CSP and vaccine-unrelated antigens in African children in the phase 3 trial.
1/2020	Antibody responses to the RTS,S/AS01E vaccine and Plasmodium falciparum antigens after a booster dose within the phase 3 trial in Mozambique.
1/2019	Differential Patterns of IgG Subclass Responses to Plasmodium falciparum Antigens in Relation to Malaria Protection and RTS,S Vaccination.
1/2019	RTS,S/AS01E immunization increases antibody responses to vaccine-unrelated Plasmodium falciparum antigens associated with protection against clinical malaria in African children: a case-control study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

James G Beeson Research Topics

Disease

152	Malaria 05/2024 - 09/2002
50	Infections 02/2024 - 10/2002
25	Falciparum Malaria (Plasmodium falciparum Malaria) 11/2023 - 07/2009
14	Parasitemia 10/2021 - 03/2009
6	Birth Weight (Birth Weights) 01/2021 - 05/2010
4	Iron Deficiencies 01/2023 - 01/2018
4	Inflammation (Inflammations) 01/2021 - 02/2011
4	Vivax Malaria 11/2019 - 12/2007
4	Reinfection 07/2014 - 09/2009
3	Anemia 01/2023 - 01/2012
3	Communicable Diseases (Infectious Diseases) 01/2021 - 10/2015
2	HIV Infections (HIV Infection) 01/2021 - 06/2004
2	Malnutrition (Nutritional Deficiencies) 01/2019 - 01/2018
1	Convalescence 10/2023
1	COVID-19 01/2021
1	Asymptomatic Infections 01/2020
1	Reproductive Tract Infections 01/2019
1	Pregnancy Complications 01/2019
1	Hepatitis B 02/2018
1	Sepsis (Septicemia) 01/2018
1	Measles 01/2017
1	Human Influenza (Influenza) 12/2015
1	Rupture 03/2013
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 01/2012

Drug/Important Bio-Agent (IBA)

90	AntibodiesIBA 05/2024 - 02/2004
63	VaccinesIBA 03/2024 - 05/2006
56	AntigensIBA 02/2024 - 09/2005
28	Immunoglobulin G (IgG)IBA 10/2023 - 06/2004
21	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2004
17	Antimalarials (Antimalarial Agents)IBA 02/2024 - 06/2004
16	Malaria VaccinesIBA 03/2024 - 01/2010
14	Complement System Proteins (Complement)IBA 01/2023 - 03/2015
13	Surface Antigens (Surface Antigen)IBA 10/2023 - 02/2004
10	Biomarkers (Surrogate Marker)IBA 01/2021 - 07/2013
8	LigandsIBA 01/2018 - 01/2008
7	IronIBA 01/2023 - 10/2015
6	artemisinin (artemisinine)IBA 01/2022 - 03/2013
6	Chondroitin Sulfates (Chondroitin Sulfate)IBA 01/2021 - 10/2002
5	Membrane Proteins (Integral Membrane Proteins)IBA 02/2023 - 05/2008
5	Immunoglobulin M (IgM)IBA 10/2021 - 08/2013
5	Merozoite Surface Protein 1 (MSA1)IBA 01/2019 - 09/2009
4	Azithromycin (Zithromax)FDA LinkGeneric 01/2022 - 07/2015
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 07/2015
4	MacrolidesIBA 01/2022 - 07/2015
4	RTS malaria vaccineIBA 01/2021 - 01/2019
3	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 10/2002
3	EpitopesIBA 01/2019 - 01/2013
2	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 02/2024 - 06/2023
2	Plasmodium falciparum erythrocyte membrane protein 1IBA 10/2023 - 01/2019
2	InsecticidesIBA 01/2020 - 12/2018
2	EnzymesIBA 07/2019 - 08/2013
2	ImmunosorbentsIBA 07/2019 - 08/2013
2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2019 - 02/2018
2	LipidsIBA 01/2019 - 02/2018
2	MicronutrientsIBA 01/2019 - 02/2018
2	Amino Acids FDA Link 01/2017 - 01/2017
2	Hormones (Hormone)IBA 10/2015 - 01/2013
2	Carrier Proteins (Binding Protein)IBA 08/2013 - 09/2009
2	GlycosaminoglycansIBA 01/2012 - 09/2002
2	Hyaluronic Acid (Hyaluronan)IBA 10/2002 - 09/2002
1	ABO Blood-Group SystemIBA 10/2023
1	Blood Group Antigens (Blood Groups)IBA 10/2023
1	N 30IBA 10/2023
1	Immunoglobulin IsotypesIBA 01/2021
1	Immunoglobulin A (IgA)IBA 01/2021
1	rebemideIBA 01/2020
1	Endothelial Protein C ReceptorIBA 01/2019
1	pyrimethamine drug combination fanasil (Fansidar)FDA Link 01/2019
1	Blocking AntibodiesIBA 01/2019
1	benzamideIBA 12/2018
1	Misoprostol (Cytotec)FDA LinkGeneric 01/2018
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018
1	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 01/2018
1	Arginine (L-Arginine)FDA Link 01/2018
1	MicroRNAs (MicroRNA)IBA 08/2017
1	Sirolimus (Rapamycin)FDA Link 01/2017
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2016
1	Monoclonal AntibodiesIBA 10/2015
1	HepcidinsIBA 10/2015
1	ArtemisininsIBA 05/2015
1	Intrinsically Disordered ProteinsIBA 01/2015
1	ProteomeIBA 01/2015
1	NexusIBA 07/2014
1	Cycloheximide (Cicloheximide)IBA 03/2013
1	trichostatin A (A 300)IBA 03/2013
1	CytokinesIBA 01/2013
1	ChemokinesIBA 01/2013
1	Peptide Hydrolases (Proteases)FDA Link 11/2012
1	signal peptide peptidaseIBA 11/2012
1	Erythrocyte Anion Exchange Protein 1 (Band 3 Protein)IBA 11/2012
1	PresenilinsIBA 11/2012
1	Drug CombinationsIBA 01/2012
1	Combined VaccinesIBA 11/2011
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 02/2011
1	Insulin-Like Growth Factor Binding ProteinsIBA 02/2011

Therapy/Procedure

6	Therapeutics 02/2024 - 05/2015
3	Aftercare (After-Treatment) 01/2022 - 01/2019
2	Chemoprevention 11/2020 - 01/2018
1	Prenatal Care (Care, Prenatal) 01/2023
1	Mass Drug Administration 11/2020